Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province

Li ZHANG; Ying ZHANG; Yudong RAO; Xueya ZHANG; Zhuo YU

doi:10.12259/j.issn.2095-610X.S20250820

Volume 46 Issue 8

Aug. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2025 > 46(8): 156-170

Li ZHANG, Ying ZHANG, Yudong RAO, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province[J]. Journal of Kunming Medical University, 2025, 46(8): 156-170. doi: 10.12259/j.issn.2095-610X.S20250820

Citation:

Li ZHANG, Ying ZHANG, Yudong RAO, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province[J]. Journal of Kunming Medical University, 2025, 46(8): 156-170. doi: 10.12259/j.issn.2095-610X.S20250820

Citation:

Li ZHANG, Ying ZHANG, Yudong RAO, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province[J]. Journal of Kunming Medical University, 2025, 46(8): 156-170. doi: 10.12259/j.issn.2095-610X.S20250820

PDF( 3983 KB)

Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province

doi: 10.12259/j.issn.2095-610X.S20250820

Li ZHANG¹,
Ying ZHANG^{2, 3},
Yudong RAO²,
Xueya ZHANG^{2, 3, 4
,
,},
Zhuo YU^{3, 4, 5
,
,}

1.
School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products，Kunming Medical University，Kunming Yunan 650500
2.
Department of Traditional Chinese Medicine，The First Affiliated Hospital of Kunming Medical University，Kunming Yunan 650032
3.
Yunnan Provincial Specialized Committee on Collaterals Disease Studies，Kunming Yunnan 650032
4.
Cardiovascular Disease Specialty Committee of Yunnan Provincial Medical Association，Kunming Yunnan 650500
5.
Department of Cardiology，The First Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032，China

More Information

Corresponding author: 　　张学娅, 四川大学华西临床医学院博士，主任医师，硕士研究生导师。国家中医药传承与创新（岐黄工程）万名骨干人才，云南省“兴滇人才”名医，云南省中医药学科带头人，主要从事中西医结合冠心病与中西医结合慢病治疗与研究工作。中国中药协会心血管病药物研究专委会委员，中国中西医结合中医基础理论专委会委员，中国中西医结合智慧医疗专委会委员，中华中医药学会综合医院中医工作委员会委员。主持国家自然科学基金1项，云南省厅级基金2项，以第一作者或通讯作者发表论文40余篇，其中SCI收录6篇。; 喻卓，北京大学博士，教授，云南省“兴滇人才” 及“心血管内科学术带头人”，现任昆明医科大学第一附属医院心血管内二科主任。拥有超过30年的临床诊疗经验，先后在德国柏林心脏中心及美国明尼苏达儿童医院进修学习冠心病及先心病介入治疗技术。兼任国家卫计委先心病介入基地培训学员导师，中国医疗保健国际交流促进会心血管疾病预防与治疗分会委员，云南省医学会行为医学分会副主任委员。擅长冠心病复杂病变的介入治疗术（percutaneous coronary intervention，PCI），对于冠心病疑难重症救治，尤其是急性心肌梗死的急诊救治、顽固性心力衰竭的综合管理、慢性冠脉综合征（chronic coronary syndrome，CCS）的规范化诊疗有深厚造诣。近年来带领团队，率先在省内开展并熟练掌握经导管主动脉瓣置换术、MitraClip钳夹术、可吸收封堵器封堵术等，积极推动心血管诊疗技术的创新与发展。主持或参与国家自然科学基金项目3项、云南省重点科研项目1项。以第一作者或通讯作者在国内外权威期刊上发表学术论文40余篇，其中SCI收录10余篇。先后荣获“云南省科技进步特等奖”，“ 卫生厅科技进步奖”，“昆明医科大学教学成果奖”等多项荣誉。
Received Date: 2025-03-04
Available Online: 2025-09-08
Publish Date: 2025-08-30

Abstract

Abstract

Chronic coronary syndrome (CCS) is one of the most prevalent cardiovascular disease (CVD) in clinical practice. With the accelerating aging of the population and the increasing prevalence of cardiovascular risk factors, CVD has become the leading cause of death among Chinese residents. To optimize diagnosis and treatment strategies through integrated traditional Chinese and Western medicine approaches, and to further improve the clinical management of CCS, the expert group reviewed recent domestic and international guidelines on CCS diagnosis and treatment. Incorporating advances in traditional Chinese medicine (TCM) and leveraging the unique characteristics of Yunnan’ s local herbal medicine (Yunyao), this consensus document was developed. It aims to guide clinical practice and enhance the overall management of CCS patients in the province.
- Chronic coronary syndrome,
- Integrated traditional Chinese and Western medicine,
- Expert Consensus,
- Characteristic drugs of Yunnan

FullText(HTML)

References(87)

References

[1]	Vrints C, Andreotti F, Koskinas K C, et al. 2024 ESC guidelines for the management of chronic coronary syndromes[J]. Eur Heart J, 2024, 45(36): 3415-537. doi: 10.1093/eurheartj/ehae177
[2]	吴勉华, 石岩. 中医内科学[M]. 北京: 中国中医药出版社, 2021: 89-97.
[3]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 慢性稳定性心绞痛诊断与治疗指南[J]. 中华心血管病杂志, 2007, 35(3): 195-206. doi: 10.3760/j.issn:0253-3758.2007.03.002
[4]	中华医学会心血管病学分会介入心脏病学组, 中华医学心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防止专业委员会. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694.
[5]	Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J, 2020, 41(3): 407-477. doi: 10.1093/eurheartj/ehz425
[6]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国慢性冠脉综合征患者诊断及管理指南[J]. 中华心血管病杂志, 2024, 52(6): 589-614. doi: 10.3760/cma.j.cn112148-20240325-00168
[7]	国家心血管病中心, 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
[8]	王吉耀, 葛均波, 邹和建. 实用内科学[M]. 第16版. 北京: 人民卫生出版社, 2022: 833-845.
[9]	Libby P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8
[10]	葛均波, 王辰, 王建安. 内科学[M]. 第10版. 北京: 人民卫生出版社, 2024: 147-156.
[11]	罗欢, 朱维, 樊瑞娟, 等. CCTA在慢性冠脉综合征患者中作为首选检查方法的临床价值[J]. 江苏医药, 2025, 51(4): 329-334+40.
[12]	Van belle E, Rioufol G, Pouillot C, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: Insights from a large French multicenter fractional flow reserve registry[J]. Circulation, 2014, 129(2): 173-185. doi: 10.1161/CIRCULATIONAHA.113.006646
[13]	Koo B K, HU X, Kang J, et al. Fractional flow reserve or intravascular ultrasonography to guide PCI[J]. N Engl J Med, 2022, 387(9): 779-789. doi: 10.1056/NEJMoa2201546
[14]	文凤, 赵健. 秋水仙碱治疗冠状动脉粥样硬化性心脏病的研究进展[J]. 国际心血管病杂志, 2024, 51(6): 329-333. doi: 10.3969/j.issn.1673-6583.2024.06.001
[15]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 经皮冠状动脉介入治疗指南(2025)[J]. 中华心血管病杂志, 2025, 53(7): 16-44.
[16]	梁媛媛, 彭鑫, 毛黎黎, 等. 血府逐瘀汤对冠心病不稳定型心绞痛痰浊痹阻型Lp-PLA2、MCP-1、sICAM-1、炎性因子及生存质量的影响分析[J]. 中华中医药学刊, 2025, 43(1): 222-226.
[17]	吴剑宏, 陈幸谊. 血府逐瘀汤方剂的现代药理研究进展[J]. 中成药, 2013, 35(5): 1054-1058. doi: 10.3969/j.issn.1001-1528.2013.05.046
[18]	邓雅文. 基于网络药理学和转录组测序的血府逐瘀汤治疗冠心病的机制研究 [D]. 北京: 中国医学科学院, 2020.
[19]	常培学, 李海波, 徐振陪. 银杏叶联合尼可地尔对药物洗脱支架治疗后老年冠心病患者多支病变的疗效分析[J]. 中华老年心脑血管病杂志, 2020, 22(3): 265-268. doi: 10.3969/j.issn.1009-0126.2020.03.011
[20]	冯锦辉, 毛祥正, 贺燕玲, 等. 银杏叶对心脑血管疾病药理作用的研究进展[J]. 陕西中医药大学学报, 2024, 47(5): 136-140.
[21]	中华中医药学会心血管分会. 冠心病稳定型心绞痛中医诊疗指南[J]. 中医杂志, 2019, 60(21): 1880-1890.
[22]	贾敏. 梁晓, 付国静, 等. 血塞通软胶囊临床应用专家共识[J]. 中国中药杂志, 2023, 48(20): 5668-5674.
[23]	霍勇, 吴宗贵, 林谦. 通心络防治冠心病临床应用中国专家共识[J]. 中国介入心脏病学杂志, 2024, 32(4): 181-190. doi: 10.3969/j.issn.1004-8812.2024.04.001
[24]	王阶, 赵涛, 熊兴江. 丹红注射液治疗冠心病的作用机制与临床疗效[J]. 中国实验方剂学杂志, 2019, 25(24): 173-178.
[25]	安冬青, 吴宗贵. 动脉粥样硬化中西医结合诊疗专家共识[J]. 中国全科医学, 2017, 20(5): 507-511.
[26]	刘红旭, 吴永健, 王显. 经皮冠状动脉介入治疗围手术期心肌损伤中医诊疗专家共识[J]. 中国中西医结合杂志, 2017, 37(4): 389-393. doi: 10.7661/j.cjim.20170219.029
[27]	付长庚, 刘龙涛, 王跃飞, 等. 丹红注射液临床应用中国专家共识[J]. 中国中西医结合杂志, 2018, 38(4): 389-397. doi: 10.7661/j.cjim.20180312.064
[28]	陈静, 陶永, 戴小华, 等. 注射用丹参多酚酸盐治疗冠心病心绞痛的疗效观察[J]. 广州中医药大学学报, 2023, 40(5): 1070-1076.
[29]	王彦, 陈加荣, 安闵生, 等. 丹参多酚酸盐治疗老年冠心病心绞痛疗效及对血脂代谢、血流动力学和心肌谱酶水平的影响[J]. 中华中医药学刊, 2021, 39(2): 199-202.
[30]	张书萌, 张湘卓, 曾雪芹. 柴胡疏肝散加减治疗冠心病心绞痛疗效的Meta分析[J]. 湖南中医药大学学报, 2020, 40(7): 867-871.
[31]	吴戈, 陆雅席, 杨苹. 基于网络药理学探讨加味柴胡疏肝散治疗冠心病伴焦虑/抑郁的作用机制[J]. 广西医学, 2023, 450(3): 309-316.
[32]	国家委员会, 国家卫生计生委合理用药会, 中国药师协会. 冠心病合理用药指南(第2版)[J]. 中国医学前沿杂志(电子版), 2018, 10(6): 1-130.
[33]	毛静远, 吴永健, 史大卓. 中成药治疗冠心病临床应用指南(2020年)[J]. 中西医结合心脑血管病杂志, 2021, 19(9): 1409-1435.
[34]	中国医师协会中西医结合医师分会心血管病专业委员会, 国家中医心血管病临床医学研究中心. 麝香保心丸治疗冠心病专家共识[J]. 中国中西医结合杂志, 2022, 42(7): 782-790. doi: 10.7661/j.cjim.20200321.010
[35]	冠状动脉微血管病中西医结合诊疗指南项目组. 冠状动脉微血管病中西医结合诊疗指南[J]. 中国中西医结合杂志, 2023, 43(9): 1029-1039.
[36]	复方丹参滴丸临床应用专家共识编写项目组. 复方丹参滴丸临床应用专家共识[J]. 中国中西医结合杂志, 2025, 45(5): 517-525.
[37]	邢晚秋. 三七丹参片通过调控VEGF/Cdc42信号通路促进血管生成改善心肌缺血的作用及机制研究[D]. 昆明: 昆明医科大学, 2024.
[38]	郑秀琴, 陈昆昌, 王留宝, 等. 三七丹参片对大鼠急性缺血大脑及心肌的保护作用研究[J]. 云南中医中药杂志, 2000, 21(5): 33-35.
[39]	黄娟, 杜扬, 徐翰, 等. 瓜蒌薤白半夏汤治疗胸痹心痛效果及安全性系统评价[J]. 山东医药, 2022, 62(20): 84-87. doi: 10.3969/j.issn.1002-266X.2022.20.021
[40]	解紫从, 何浩强, 高嘉良, 等. 涤痰汤加减治疗冠心病心绞痛有效性及安全性的Meta分析[J]. 中国临床保健杂志, 2021, 24(1): 33-38. doi: 10.3969/J.issn.1672-6790.2021.01.010
[41]	沈仲琪, 刘明阳, 董振飞. 基于网络药理学及分子对接探寻仲景瓜蒌薤白半夏汤治疗冠心病的活性成分及作用机制[J]. 时珍国医国药, 2022, 33(10): 2550-2553. doi: 10.3969/j.issn.1008-0805.2022.10.73
[42]	高诗雨, 董悦, 严晨涛, 等. 丹蒌片联合西药治疗冠心病的疗效及安全性Meta分析[J]. 世界中西医结合杂志, 2024, 19(2): 233-239.
[43]	吴茜, 侯信铮, 吕乾瑜, 等. 痰瘀同治法(丹蒌片)对动脉粥样硬化患者血管内皮功能的作用[J]. 中国实验方剂学杂志, 2025, 31(12): 168-175.
[44]	李增, 张明雪. 基于复方网络药理学和分子对接技术研究丹蒌片治疗冠心病的作用机制[J]. 辽宁中医杂志, 2023, 50(1): 120-124+222.
[45]	周盾, 凌家艳, 余浩, 等. 当归四逆汤合督脉灸治疗寒凝心脉型微血管性心绞痛疗效观察[J]. 中华中医药学刊, 2024, 42(10): 232-235.
[46]	刘嘉宁, 张雅萍. 枳实薤白桂枝汤联合西药治疗寒凝气滞兼痰瘀证不稳定型心绞痛临床研究[J]. 新中医, 2023, 55(20): 36-39.
[47]	王镕, 况春燕. 基于网络药理学和分子对接研究当归四逆汤治疗稳定型心绞痛的作用机制[J]. 河南中医, 2024, 44(12): 1880-1887.
[48]	何湛湛, 杨桢, 亓玉婕, 等. 枳实薤白桂枝汤现代药理作用研究进展[J]. 中国实验方剂学杂志, 2023, 29(6): 254-259.
[49]	Li D, Xie J, Ren Y, et al. Effectiveness and safety of acupoint application of Guan Xin Su He Pill (冠心苏合丸) for patients with chronic stable angina pectoris: A multi-center, randomized controlled trial[J]. Chin J Integr Med, 2021, 27(11): 838-45.
[50]	刘剑锋, 况春燕, 郭慧. 基于网络药理学方法和分子对接技术探讨冠心苏合丸治疗冠心病的有效成分及作用机制[J]. 山西中医药大学学报, 2023, 24(5): 547-554.
[51]	易鑫颖, 周宇轩, 彭添凤, 等. 生脉散治疗心系疾病及其作用机制[J]. 生命的化学, 2024, 44(8): 1376-1383.
[52]	江雨洁, 张湘卓, 张书萌, 等. 生脉散加减联合西药常规治疗冠心病心绞痛Meta分析[J]. 世界中医药, 2017, 17(20): 2885-2891.
[53]	王萍, 赵姿雯, 王丁丁, 等. 生脉饮的化学成分、药理作用和临床应用进展[J]. 天津中医药大学学报, 2024, 43(6): 565-570.
[54]	Chen Y, Wang L, Li Y, et al. Efficacy and safety of shensong yangxin capsules for persistent atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2025, 16: 1620340. doi: 10.3389/fphar.2025.1620340
[55]	谢俊大, 钟萌, 吴真. 参松养心胶囊的药理毒理与临床研究概况[J]. 中国药房, 2008(33): 2628-2631.
[56]	国家中医心血管病临床医学研究中心, 中国医师协会中西医结合医师分会, 生脉类注射剂临床应用中国专家共识编写组. 生脉类注射剂临床应用中国专家共识[J]. 中国中西医结合杂志, 2020, 40(12): 1430-1438.
[57]	郭贺杰, 李雯, 张亚娜. 益气复脉注射液辅治不稳定型冠心病心绞痛临床观察[J]. 实用中医药杂志, 2025, 41(3): 550-552.
[58]	周康. 益气复脉注射液联合重组人脑利钠肽在心房颤动伴慢性心力衰竭治疗中的临床效果观察[J]. 心血管病防治知识, 2025, 15(2): 38-41.
[59]	王广艳, 腾名子, 朱君. 天王补心丹加减治疗心房颤动合并冠心病阴虚火旺证的临床观察[J]. 中国实验方剂学杂志, 2018, 24(17): 189-94.
[60]	何俊明, 陈光, 李洪峥, 等. 炙甘草汤治疗心血管病方论新析及循证进展[J]. 中华中医药杂志, 2020, 35(3): 1365-1367.
[61]	王常普. 加用六味地黄丸加减治疗冠心病心绞痛30例[J]. 广西中医药, 2015, 38(4): 27-28.
[62]	童黄锦, 杨月东, 邓良英. 六味地黄丸对肾阴虚型绝经后女性冠心病经皮冠状动脉介入治疗术后的临床研究[J]. 中国医院药学杂志, 2022, 42(14): 1469-1473.
[63]	葛昭, 杨志华, 刘春香, 等. 六味地黄丸在心血管疾病的应用价值及网络药理学多靶点效应价值研究进展[J]. 世界中医药, 2022, 17(12): 1783-1787. doi: 10.3969/j.issn.1673-7202.2022.12.026
[64]	霍嘉琪, 田厚泽, 张雅玲, 等. 芪苈强心胶囊对慢性心力衰竭合并冠心病患者的疗效观察[J]. 中华中医药学刊, 2025, 50(1): 101-103.
[65]	吴楠. 芪苈强心胶囊对冠心病并发心力衰竭患者的疗效[J]. 辽宁中医杂志, 2025, 52(5): 133-136.
[66]	刘剑锋, 况春燕. 基于网络药理学和分子对接技术探讨芪苈强心胶囊治疗冠心病的有效成分及作用机制[J]. 山西中医药大学学报, 2023, 24(11): 1248-1256.
[67]	Zhou X, Miao J, Zhuang Q, et al. Meta-analysis on effect of shenfu injection in treating angina pectoris[J]. Zhongguo Zhong Yao Za Zhi, 2016, 41(3): 536-540.
[68]	Wang X, Guo R, Guo Y, et al. Rationale and design of the restore trial: A multicenter, randomized, double-blinded, parallel-group, placebo-controlled trial to evaluate the effect of shenfu injection on myocardial injury in STEMI patients after primary PCI[J]. Am Heart J, 2023, 260: 9-17. doi: 10.1016/j.ahj.2023.02.005
[69]	Xu F, Xie X F, Hu H Y, et al. shenfu injection: A review of pharmacological effects on cardiovascular diseases[J]. Front Pharmacol, 2024, 15: 1279584. doi: 10.3389/fphar.2024.1279584
[70]	包宇, 彭广操, 周怡, 等. 中医适宜技术规范化治疗稳定型心绞痛研究进展[J]. 中华中医药杂志, 2024, 39(6): 2991-2996.
[71]	何花, 谭畅. 通痹复律安心加减方联合耳穴压豆治疗冠心病心绞痛[J]. 吉林中医药, 2024, 44(11): 1309-1313.
[72]	陈科, 张罗健, 万峰. 刮痧的现代研究与临床应用[J]. 中国民族民间医药, 2011, 20(4): 4-5+8. doi: 10.3969/j.issn.1007-8517.2011.04.004
[73]	张文文. 中药熏洗配合穴位按摩对冠心病失眠患者的影响[J]. 中西医结合心血管病电子杂志, 2022, 10(16): 80-83.
[74]	袁丽霞, 丁荣晶. 中国心脏康复与二级预防指南解读[J]. 中国循环杂志, 2019, 34(S1): 86-90.
[75]	林梅兰, 王珊, 江芷珊, 等. 真武汤联合八段锦对老年冠心病患者心肺运动功能及生存质量的影响[J]. 广州医药, 2024, 55(12): 1470-1475.
[76]	Wen C, Liao X, Ye X, et al. Pharmacokinetics and biological activities of notoginsenoside R1: A systematical review[J]. Am J Chin Med, 2025, 53(1): 205-249. doi: 10.1142/S0192415X25500090
[77]	张莉, 杨建宇, 杨艳, 等. 三七总皂苷调节PDGF-BB/PDGFR-β 的表达促进大鼠浅表Ⅱ°烧伤创面愈合[J]. 昆明医科大学学报, 2021, 42(6): 7-15.
[78]	Mo J, Yang R H, Li F, et al. Scutellarin protects against vascular endothelial dysfunction and prevents atherosclerosis via antioxidation[J]. Phytomedicine, 2018, 42: 66-74.
[79]	张莉, 余丹, 王雨婷, 等. 灯盏乙素对ox-LDL 损伤的RAW264.7 细胞中PKC 和TNF-α 表达的影响[J]. 昆明医科大学学报, 2021, 42(10): 1-7.
[80]	支英杰, 赵君, 赵晖, 等. 灯盏花素注射剂治疗不稳定型心绞痛的有效性和安全性: 随机对照试验的系统评价和Meta分析[J]. 中国中药杂志, 2018, 43(19): 3940-3955.
[81]	Xie J, Wang Y Y, Li J X, et al. Effect and mechanism of poria cocos polysaccharides on myocardial cell apoptosis in rats with myocardial ischemia-reperfusion injury by regulating Rho-ROCK signaling pathway[J]. Zhongguo Zhong Yao Za Zhi, 2023, 48(23): 6434-6441.
[82]	Zhan H D, Zhou H Y, Sui Y P, et al. The rhizome of Gastrodia elata Blume-An ethnopharmacological review[J]. J Ethnopharmacol, 2016, 189: 361-385.
[83]	Du R, Guo Y, Zhong W, et al. Gastrodin alleviates myocardial infarction by inhibiting inflammation, and apoptosis and promoting endothelial cell proliferation[J]. Biochem Biophys Rep, 2025, 42: 102014.
[84]	Gong M Q, Lai F F, Chen J Z, et al. Traditional uses, phytochemistry, pharmacology, applications, and quality control of Gastrodia elata Blume: A comprehensive review[J]. J Ethnopharmacol, 2024, 319(Pt 1): 117128.
[85]	Guo L, Cheng B X, Guo Q S, et al. Effects of harvest and different processing methods on anti-thrombin activity of poecilobdella manillensis[J]. Zhongguo Zhong Yao Za Zhi, 2016, 41(11): 2087-2092.
[86]	韩瑾, 宋研博, 孙永康, 等. 水蛭药理作用及其在脑病中的应用[J]. 中华中医药学刊, 2024, 42(5): 147-150.
[87]	Wu S, Zhou Y, Wang Y, et al. Therapeutic potentials of medicinal leech in Chinese medicine[J]. Am J Chin Med, 2024, 52(4): 1027-1051. doi: 10.1142/S0192415X24500423

Relative Articles(20)

Relative Articles

[1]	Yuzhen ZHAO, Yingyan MA, Lili HE. Analysis of the Value of Serum Testosterone，Sex Hormone-Binding Globulin and Vitamin D Levels in Predicting Gestational Diabetes Mellitus Complicated by Polycystic Ovary Syndrome. Journal of Kunming Medical University, 2025, 46(8): 1-7.
[2]	Li ZHANG, Ying ZHANG, Xueya ZHANG, Zhuo YU. Expert Consensus on the Diagnosis and Treatment of Chronic Coronary Syndrome with Traditional Chinese and Western Medicine in Yunnan Province. Journal of Kunming Medical University, 2025, 46(): 1-21.
[3]	Xiaodong ZHANG, Nan NIU, Ying LIU, Jiajie MEI, Zhaohong GENG, Hongyan WANG. Effect of Nicorandil on Inflammation-related Markers after PCI Intervention in Patients with Acute Coronary Syndromes. Journal of Kunming Medical University, 2024, 45(2): 136-140. doi: 10.12259/j.issn.2095-610X.S20240219
[4]	Jin-yun CAI, Juan WANG, Rui-xi SUN, Ping FU. Clinical Features of Rhupus Syndrome. Journal of Kunming Medical University, 2021, 42(2): 64-69. doi: 10.12259/j.issn.2095-610X.S20210201
[5]	Xing LIU, Bing OUYANG, Na LI, Ji LUO, Xu-qin SHI, Jie CHEN, Hui SUN, Hai-wen LI. Effect and Economic Evaluation of the Combination of Traditional Chinese and Western Medicine in Treatment of MDR-TB. Journal of Kunming Medical University, 2020, 41(11): 49-54. doi: 10.12259/j.issn.2095-610X.S20201106
[6]	Yuan Hai Feng , Su Xue Wen , Li Tian Chang . Correlative Analysis of the Onset Age of Acute Coronary Syndrome with Previous Diseases. Journal of Kunming Medical University, 2017, 38(06): 32-35.
[7]	Li Rui Jie . Risk-Treatment Paradox in Acute Coronary Syndrome. Journal of Kunming Medical University,
[8]	Li Xiao Fei . The Influence of the Integrated Traditional Chinese and Western Medicine Treatment on Serum Levels of TNF-α， IL-6 and Endotoxin of Patients with Hepatic Failure. Journal of Kunming Medical University,
[9]	Qing Yan Ping , Tan Shu , Zhu You Shan , Yang Shu Hua . Application of Integrative Medicines of TCM and WM Combined with Fast-track Surgery Concept in Perioperative Nursing in Colorectal Surgery. Journal of Kunming Medical University, 2016, 37(12): 148-150.
[10]	Li Wen Chang . Comparison of the Effect of Chinese and Western Medicine and Western medicine on Senile Osteoporosis. Journal of Kunming Medical University,
[11]	Hao Ying Lu . . Journal of Kunming Medical University,
[12]	Wei Wei . . Journal of Kunming Medical University,
[13]	Zhang Yan . . Journal of Kunming Medical University,
[14]	Li Xiao Ting . . Journal of Kunming Medical University,
[15]	Jiang Fan. . Journal of Kunming Medical University,
[16]	Li Jia Xiang . . Journal of Kunming Medical University,
[17]	. The Value of Ankle-brachial Index Combined with Brachial Ankle Pulse Wave Velocity in Patients with Acute Coronary Syndrome. Journal of Kunming Medical University,
[18]	. Clinical analysis of Fondaparinux in Treatment of Acute Coronary Syndromes after Interventional Therapy. Journal of Kunming Medical University,
[19]	. The Application of Intraaortic Balloon Counterpulsation in Acute Coronary Syndrome. Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,